News

Aurinia Pharmaceuticals recently announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to voclosporin, a next-generation calcineurin inhibitor under development to treat patients with lupus nephritis (LN) and other autoimmune diseases. LN is a kidney inflammation caused by systemic lupus erythematosus (SLE) in which patients may develop proteinuria,…

Researchers from Singapore’s leading science institute, A*STAR, found that a group of small noncoding RNAs, called mir-17-92, regulate B-cell function and antibodies in mice. The results may help pave the way for new lupus treatments and other diseases linked to B-cell dysfunction. Antibody-producing B-cells are a crucial part of our defense against pathogens. In autoimmune…

Immunovia AB recently announced it has entered into a collaboration with a large multinational life science company to jointly conduct trials to expand the application of IMMray, a technology platform based on antibody microarray analysis, to include autoimmune diseases like systemic lupus erythematosus (SLE). The company was not otherwise…

A collaborative research project conducted between The Scripps Research Institute in La Jolla, California; Yale University  in New Haven, Connecticut; and National Biotechnology Center in Madrid, Spain, has identified a small molecule called miR-148a as a key regulator of immune cells, where higher levels appear to cause autoimmune diseases. The paper, “…